Strides Pharma Science gets EIR from USFDA for formulations facility in Bangalore

06 Feb 2019 Evaluate

Strides Pharma Science has received the Establishment Inspection Report (EIR) there by confirming the successful closure of the inspections for formulations facility (KRSG Gardens) in Bangalore which was inspected by the US Food and Drug Administration (USFDA) in August 2018 and November 2018.

The inspection conducted in November 2018 had concluded with Zero 483 observations. The flagship facility in Bangalore manufacturers tablets, capsules, liquids, creams ointments, sachets. The facility is the largest for company and supports several current and future products for the US markets.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

805.25 9.05 (1.14%)
29-Jan-2026 09:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1603.95
Dr. Reddys Lab 1204.30
Cipla 1321.50
Zydus Lifesciences 889.50
Lupin 2113.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×